Vanguard Group’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,709,967
Closed -$261K 4620
2023
Q2
$261K Buy
1,709,967
+1,009,167
+144% +$157K ﹤0.01% 4262
2023
Q1
$101K Hold
700,800
﹤0.01% 4405
2022
Q4
$84.1K Sell
700,800
-61,323
-8% -$8.85K ﹤0.01% 4408
2022
Q3
$137K Sell
762,123
-1,692,661
-69% -$911K ﹤0.01% 4465
2022
Q2
$4.34M Buy
2,454,784
+25,799
+1% +$57.9K ﹤0.01% 3447
2022
Q1
$7.31M Sell
2,428,985
-64,936
-3% -$174K ﹤0.01% 3314
2021
Q4
$9.28M Sell
2,493,921
-289,391
-10% -$1.69M ﹤0.01% 3256
2021
Q3
$16.5M Buy
2,783,312
+538,648
+24% +$7.57M ﹤0.01% 2967
2021
Q2
$39M Buy
2,244,664
+415,409
+23% +$7.57M ﹤0.01% 2498
2021
Q1
$34.9M Buy
1,829,255
+213,545
+13% +$3.9M ﹤0.01% 2500
2020
Q4
$28.3M Buy
+1,615,710
New +$19.3M ﹤0.01% 2476

Other funds holding HGEN

Vanguard Group's HGEN Position: Q3 2023 in Review

Vanguard Group sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 1,709,967 shares — an estimated $261K sold.

Vanguard Group first reported a position in HGEN in Q4 2020 and held it in 11 quarters. The position peaked at $39M in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

  • Vanguard Group reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
  • Vanguard Group sold 1,709,967 HUMANIGEN, INC. shares in Q3 2023, an estimated $261K.
  • Vanguard Group first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 11 quarters.
  • Vanguard Group's HUMANIGEN, INC. position peaked at $39M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.